DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Paralysis are 18




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
References
DrugRepV_7354Glycine-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
Increase (16.37 %)
NA
14011545
DrugRepV_7355DL-Phenylalanine-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
No significant effect (3.63 %)
NA
14011545
DrugRepV_7356L-Leucine-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
No significant effect (3.63 %)
NA
14011545
DrugRepV_7357DL-Aspartic acid -Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
Decrease (23.63 %)
NA
14011545
DrugRepV_7358DL-Asparagine-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
Decrease (36.36 %)
NA
14011545
DrugRepV_7359DL-Alanine-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
Increase (9 %)
NA
14011545
DrugRepV_7360L-Cysteine-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
Decrease (18.18 %)
NA
14011545
DrugRepV_7361DL-Lysine-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
Increase (9 %)
NA
14011545
DrugRepV_7362L-Tyrosine-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
No significant effect (10 %)
NA
14011545
DrugRepV_7363DL-Methionine-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
Increase (20 %)
NA
14011545
DrugRepV_73642-Picolinic acid-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
Increase (0.45 %)
NA
14011545
DrugRepV_7365Guanidine-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
Increase (9.5 %)
NA
14011545
DrugRepV_7366Diethyl Dithiocarbamic Acid-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
Increase (27.72 %)
NA
14011545
DrugRepV_7367Diphenylthiocarbazone-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
Increase (12.14 %)
NA
14011545
DrugRepV_73688-Hydroxyquinoline-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
No significant effect (8.6 %)
NA
14011545
DrugRepV_73693,4-Dimercaptotoluene-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
Increase (10 %)
NA
14011545
DrugRepV_73701,10-Phenanthroline-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
No significant effect (5 %)
NA
14011545
DrugRepV_73711,10-Phenanthroline-3,4-dimercaptotoluene-Zn
NA
NA
Japanese encephalitis virus
Nakayama
Pathway
Paralysis
Decrease (35 %)
NA
14011545